Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer, and idiopathic pulmonary fibrosis are available to patients, and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide.

Caris Molecular Profiling Institute, Inc. provides research and laboratory testing services. It offers tests to help oncologists to understand and treat cancer patients with personalized treatment plans based on the molecular characteristics of their tumors. The company offers services to the hospitals, physicians, and clinical research sponsors. Caris Molecular Profiling Institute was founded on 1996 and is headquartered in Phoenix, AZ.

NantOmics develops cloud-based molecular profiling tools that help guide cancer patients. It is a molecular diagnostics company, develops molecular profiling solutions that identify personalized treatment options for cancer patients and their providers at the point of care. It offers GPS Cancer test that provides a molecular profile of patient’s cancer to inform personalized treatment strategies to oncologists and OncoPlexDx Targeted Proteomic panel that provides quantitative protein biomarker information for multiple clinically relevant proteins yielding insights into the biology driving the growth of the patient’s cancer. Patrick Soon-Shiong founded NantOmics in 2012, with its headquarters in Culver City, California. NantOmics operates as a subsidiary of NantWorks.

Syntekabio is a Korean biotech firm, developing personal genome map which is expected to enable personalized medical service. The company also provides a technology for collecting and integrating decrypted whole genome data.

Distrival SAS, a subsidiary of Carrefour SA, is a company headquartered in Mondeville, France. The firm operates supermarkets. It was founded in 1991.

Syngenta AG is a global company that produces agrochemicals and seeds and is based in Basel, Switzerland. As a biotechnology company, it conducts genomic research. It was formed in 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. As of 2014 Syngenta is the world’s largest crop chemical producer As of 2009 it ranked third in seeds and biotechnology sales. Sales in 2015 were approximately US$13.4 billion, over half of which were in emerging markets. It is owned by ChemChina, a Chinese state-owned enterprise.

Berg is a Swiss private company located in Berg, with subsidiaries in Spain, providing investment services.

Five3 Genomics, LLC offers cancer genome data processing services. The company provides genome processing services for researchers including alignment, mutational calling, rearrangement detection, and copy number estimation. It caters to research, biotech, and patient care sectors. Five3 Genomics, LLC is based in Santa Cruz, California.

Assistance Publique H��pitaux de Marseille is a private company headquartered in Marseille, France, specializing in general medical and surgical hospitals.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

VistaGen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia). The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA.

Diomics focused on the development of therapeutic applications for Diomat polymer including biomaterial implants for cell therapy and transdermal drug delivery applications. As a life science discovery and development continue to move toward a better understanding of biological responses to disease, the need for high-throughput, quality sample preparation and analysis becomes even more critical. That's why Diomics is committed to providing innovative automation solutions through its materials and technologies that will lead the way to remarkable life science discoveries. It was founded in 2009 and is headquartered in Carlsbad, California.

Cure Forward is a healthcare company that specializes in the fields of genomic medicine, consumer healthcare, oncology, and clinical trials. The company helps cancer patients and physicians access advanced treatments in oncology. It was founded in 2014 and is headquartered in Boston, Massachusetts.

CeMines, Inc. develops technology for the detection and treatment of cancer. The firm provides diagnostic tests for lung, breast, gastrointestinal, and leukemia. The company was founded by Richard Cavalli, Toomas Neuman and Kaia Palm in 2000 and is headquartered in Golden, CO.